Pliant Therapeutics, Inc., a late─stage biopharmaceutical company and leader in the discovery and development of novel therapeutics for the...

Duke University and Duke-NUS Medical School are proud to announce the recipients of their latest Research Collaboration Pilot Project grants,...

After it was announced Tuesday that Pope Francis has been diagnosed with bilateral pneumonia, the Vatican has issued an update that his condition has...

Ingelheim, Germany, February 10, 2025 - Boehringer Ingelheim announced today that the FIBRONEER™-ILD trial met its primary endpoint, which was...

A court battle resumed Friday over the Trump administration's drastic cuts in medical research funding that many scientists say will endanger patients...

Dr Manisha Mendiratta, associate director & head ─ pulmonology, Sarvodaya Hospital, Faridabad emphasizes the importance of early detection and the...

Mumbai reported first case of Guillain-Barré Syndrome (GBS) in 2025 on Friday after a 64-year-old woman was diagnosed with the rare nerve disorder,...

New drugs and a growing awareness of the common condition offer hope for patients.

New antibody AHA-1031 shows potential in treating non small cell lung cancer resistant to immunotherapy, offering new hope.

by Darrell Ehrlick, Daily Montanan February 10, 2025 Just a little more than 90 days ago, Montana voters soundly approved a state constitutional...